DTA Home 2018-06-01T11:55:43+00:00

Digital Therapeutics Alliance

Improving healthcare quality, outcomes, and value through optimizing the use and integration of digital therapeutic solutions

Learn More

What are Digital Therapeutics?

Digital therapeutics represent a new generation of healthcare that uses innovative, clinically-validated disease management and direct treatment applications to enhance, and in some cases replace, current medical practices and treatments.

DTx products demonstrate safety and efficacy in randomized clinical trials, receive regulatory clearance when used as a medical device, integrate into clinical practice, may be prescribed by healthcare providers, and tailor to patients’ clinical needs, goals, and lifestyles.


Digital Therapeutics Alliance

The Digital Therapeutics Alliance is a global non-profit trade association with the mission of broadening the understanding, adoption, and integration of clinically-validated digital therapeutics into healthcare through education, advocacy, and research.

The Alliance provides a platform for leading DTx companies to engage with patients, healthcare providers, payers, academic institutions, technology organizations, and pharmaceutical manufacturers.

DTA members collaborate to enhance patient outcomes through assessing the value and impact of DTx solutions in clinical practice, constructing industry and regulatory frameworks, and encouraging data-driven integration and utilization of DTx solutions across the healthcare industry.

Learn more

DTA News

Digital Therapeutics Alliance and USP Announce Collaboration

WASHINGTON, June 4, 2018 /PRNewswire-USNewswire/ – The Digital Therapeutics Alliance (DTA) and USP announced a collaboration to explore the development of appropriate standards and guidelines for digital therapeutics at a roundtable discussion co-hosted by the two organizations today at USP [...]

The Digital Therapeutics Alliance Announces New Members

Arlington, VA — May 8, 2018 — The Digital Therapeutics Alliance welcomes nine companies to membership: Bayer, Big Health, Cognoa, Kaia Health, Merck, Omada Health, Otsuka America Pharmaceutical, Inc., Pear Therapeutics, and Sanofi. “Digital medicine has the potential to safely and effectively [...]

Digital Therapeutics Alliance Announces 2018 Strategic Advisors

Arlington, VA – May 8, 2018 – The Digital Therapeutics Alliance welcomes ten global thought leaders as 2018 Strategic Advisors. These individuals will engage with DTA leaders and members to establish and progress the Alliance's goals and initiatives.  Andrew Matzkin: Health Advances [...]

Read More

Stay in Touch


Get Connected